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ABSTRACT (Maximum 200 words)
The potential toxicities of compounds to replace current US Air Force operational chemicals is of particular interest. A group of jet fuel system ice-inhibiting agent alternatives currently being evaluated for performance include derivatives of 1,3-dioxolane-4-methanols and 1,3-dioxanes. The experiments presented here were performed in support of Air Force Research Laboratory's Materials Directorate research on FSII alternatives. Our initial approach to evaluating potential toxicity utilized primary rat hepatocyte cultures for assessing acute toxicity. The experiments summarized here were performed to develop analytical methods for these chemicals and the assessment of potential variations in the aqueous concentrations of the test chemicals during cell culture experiments due to volatilization. The test chemicals were prepared at lmM and 10mM concentrations and incubated in 6-well culture plates at 37 C for 0-6 hrs. Aliquots were taken at time intervals and analyzed by gas chromatography. These concentrations indicate the potential in vitro dosimetry for the cells in culture. The results indicate that for all but one (M-27) for M-DE and M-PE there was no significant change in chemical concentration of the chemicals tested, the aqueous concentrations do not vary substantially from their initial concentration over a six hour incubation.
14. The development of fuel system ice inhibitors is an example of an integrated approach to designing new operational compounds that are potentially the least toxic, while exhibiting acceptable performance characteristics [2] . This project involves our toxicology lab, as well as scientists from the Materials Directorate of the Air Force
Research Laboratory. When undertaking the selection of chemicals that are to be developed and pursued, current DoD acquisition strategies take into consideration the potential toxicities associated with human exposure to those chemicals of interest [3, 4] .
The utilization of various in vitro testing approaches is intended to assist our ability to address the question of potential chemical toxicity in a strategic and timely fashion. Our initial approach to evaluating the potential toxicities of these chemicals includes the assessment of acute toxicity in primary rat hepatocyte cultures.
Dosimetry is a concern in toxicology, both in vivo and in vitro. Monitoring of blood, tissue, or media concentrations is performed routinely to determine the levels of test chemical that are potentially available to the target tissue, cell, or molecule. Solubility, phase partitioning, and volatility are some of the factors affecting the bioavailability of a chemical.
In order to address the potential role of volatility on in vitro dosimetry, experiments were performed to develop analytical methods for the detection and quantification of these chemicals and to assess the potential variations in aqueous concentrations of the test chemicals during cell culture experiments, due to volatilization. Potential volatilization of the test article is a concern for the in vitro testing of these FSIIs. The rate of loss of a * chemical from the aqueous phase into the gas phase is a function of the concentration gradient, the concentration decrease from the aqueous phase would follow a pattern of exponential decay [5] . Thus, although in vitro exposures are often conducted for periods greater than 12 hours, the greatest change in concentration would have occurred before 6 hours. This means that an initial assessment out to 6 hours would provide sufficient insight into whether the change in chemical concentration would be substantial.
Here, we chose concentrations of 1 and 10 millimolar (mM) for these experiments, because those concentrations are at the upper end of the doses used in our standard in vitro testing design. These doses are sufficient to elicit biological response in vitro [3, 4] .
The dosimetry experiments were conducted at 37 0 C, since that is the temperature at which the cells in media would be exposed and incubated with these chemicals. The Table 2 ). .ý 
M-DE
750C increased 1lC/min to 850C
M-DP
850C increased 1lC/min to 950C (Figs. 1, 5 , 7, 9, 13), the peak areas for the major peaks was used for estimating the chemical concentration. For M-2 (Fig. 3) , the four major peaks were used for concentration estimation. For M-DP (Fig. 11) , the two major identified peaks were used.
M-EG
Methods for GC/FID analysis of compounds M-3 ( Fig. 15) , M-26 (Fig. 16 ) and M-EG (Fig. 17) , M-EM (Fig. 18) , and M-G (Fig. 19) were developed. However, these chemicals were not used in the dosimetry experiment. M-3, M-EM, and M-G gave insufficient separation by GC analysis. Elapsed Time (hr)
Changes in chemical concentration were statistically significant (p<0.05, r 2 >0.6) for M-1 at 10mM (Fig. 23) , and M-22 at 1mM (Fig. 26) . However, after 6 hours the net changes in the concentrations of the M-1 and M-22 compounds were less than ten percent (10%) of the initial concentrations (at to). These changes were not considered biologically relevant to experimental testing conditions, since a change less than 10% after 6 hours corresponds to a t,, 2 Elapsed Time (hr)
The changes in concentration for M-27 at both 1 and 10mM (Fig. 23 ) were significant and relevant. At 1 mM, after 6 hours, the concentration decreased 60%, corresponding to a t 112 of 4.5h (p<0.05, r 2 =0.90). For 10amM, after 6 hours, the concentration had decreased 70%, corresponding to a t 112 of approximately 3.5h (p<0.05, r 2 =0.962).
These changes in M-27 over this time period are a potential concern for in vitro testing of this chemical.
21
A modification in dosing regimen should be considered when assessing the toxicity of M-27 with dosing periods greater than a few hours. Without such modifications, the toxicity of M-27 may be underestimated by certain in vitro testing systems. For M-2, M-DE, M-DP and M-PE there were no significant changes in chemical concentrations. V.
